insights_auto
Bakit bumaba ang 0QF 4.14%?
Tingnan ang Higit pang Detalyechevron_right
0QF:ETR
Moderna Inc
€189.09
arrow_downward
-4.14%(-8.17) 1D
Okt 13, 1:05:27 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 0QF...
Buksan
€190.10
Mataas
€194.34
Mababa
€187.00
Mkt. cap
85.33B
Avg. na dami
28.34K
Dami
8.23K
Mataas nang 52-wk
€194.34
Mababa nang 52-wk
€19.37
Bilang ng mga empleyado
5K
Buksan
€190.10
Mataas
€194.34
Mababa
€187.00
Mkt. cap
85.33B
Avg. na dami
28.34K
Dami
8.23K
Mataas nang 52-wk
€194.34
Mababa nang 52-wk
€19.37
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
2 oras ang nakalipas
Analysts raise target for Moderna stock to USD 118.42
The Motley Fool
·
2 oras ang nakalipas
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?
TIKR.com
·
8 oras ang nakalipas
Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines
Simply Wall Street
·
11 oras ang nakalipas
Moderna Stock Puts MRNA Cancer Vaccine Shares Back In Focus
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Tungkol sa Moderna Inc